Biddle, K; Buckeldee, O; Latheef, A; Al-Shakarchi, I; Sofat, N
(2023)
REAL-WORLD USE OF JAK INHIBITORS IN RHEUMATOLOGICAL PRACTICE IN SOUTH LONDON.
In: EULAR 2023 European Congress of Rheumatology, ANNALS OF THE RHEUMATIC DISEASES, 31 May - 3 June 2023, Milan, Italy.
SGUL Authors: Sofat, Nidhi
|
PDF
Accepted Version
Available under License ["licenses_description_publisher" not defined]. Download (194kB) | Preview |
Official URL: https://doi.org/10.1136/annrheumdis-2023-eular.705
| Item Type: | Conference or Workshop Item (UNSPECIFIED) |
|---|---|
| Additional Information: | This article has been accepted for publication in Annals of the Rheumatic Diseases, 2023 following peer review, and the Version of Record can be accessed online at https://doi.org/10.1136/annrheumdis-2023-eular.705. © Author(s) (or their employer(s)) 2023. |
| Keywords: | Targeted synthetic drugs, Rheumatoid arthritis, Psoriatic arthritis, 1103 Clinical Sciences, 1107 Immunology, 1117 Public Health and Health Services, Arthritis & Rheumatology |
| SGUL Research Institute / Research Centre: | Academic Structure > Infection and Immunity Research Institute (INII) |
| Journal or Publication Title: | ANNALS OF THE RHEUMATIC DISEASES |
| Article Number: | AB0450 |
| ISSN: | 0003-4967 |
| Publisher License: | Publisher's own licence |
| Web of Science ID: | WOS:001107398704487 |
| URI: | https://openaccess.sgul.ac.uk/id/eprint/116245 |
| Publisher's version: | https://doi.org/10.1136/annrheumdis-2023-eular.705 |
Statistics
Item downloaded times since 21 Feb 2024.
Actions (login required)
 |
Edit Item |